| Alina Geller, DO | |
|
1003 N Providence Dr Ste 340, Newberg, OR 97132-7521 | |
| (503) 538-2698 | |
| (503) 554-9328 |
| Full Name | Alina Geller |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 16 Years |
| Location | 1003 N Providence Dr Ste 340, Newberg, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891053088 | NPI | - | NPPES |
| 500650104 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 277353 (New York) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 156918 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Womens Healthcare Associates Llc | 8527054014 | 94 |
News Archive
AMRI today announced the acquisition of Hyaluron Inc., expanding AMRI's contract manufacturing capabilities to include cGMP manufacturing and sterile filling of parenteral drugs to the biopharmaceutical industry. AMRI has acquired all facilities and equipment as well as a highly trained and experienced staff of professionals with expertise in sterile GMP manufacturing. Purchase price, including debt, was approximately $27 million.
Endo Pharmaceuticals today issued a voluntary nationwide consumer level recall of Endocet (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg 100 count bottles, NDC 60951-712-70, Lot # 402415NV and #402426NV.
Experts from the world's leading lung organisations have come together for the first time to call for a worldwide effort to improve healthcare policies, systems and care delivery to make a positive difference to the lung health of the world.
Taiho Pharmaceutical Co., Ltd. (Tokyo, President: Masayuki Kobayashi) announced on March 24 that it has obtained approval in Japan from the Ministry of Health, Labour and Welfare to manufacture and market the oral combination anticancer drug "Lonsurf(R) combination tablet T15, T20" (nonproprietary names: trifluridine and tipiracil hydrochloride; development code: TAS-102), for the treatment of patients with unresectable advanced or recurrent colorectal cancer (only if refractory to standard therapies).
Air pollution has already been linked to a range of health problems. Now, a ground-breaking new study suggests pollution from traffic may put women at risk for another deadly disease.
› Verified 4 days ago
| Entity Name | Womens Healthcare Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346296142 PECOS PAC ID: 8527054014 Enrollment ID: O20040421000823 |
News Archive
AMRI today announced the acquisition of Hyaluron Inc., expanding AMRI's contract manufacturing capabilities to include cGMP manufacturing and sterile filling of parenteral drugs to the biopharmaceutical industry. AMRI has acquired all facilities and equipment as well as a highly trained and experienced staff of professionals with expertise in sterile GMP manufacturing. Purchase price, including debt, was approximately $27 million.
Endo Pharmaceuticals today issued a voluntary nationwide consumer level recall of Endocet (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg 100 count bottles, NDC 60951-712-70, Lot # 402415NV and #402426NV.
Experts from the world's leading lung organisations have come together for the first time to call for a worldwide effort to improve healthcare policies, systems and care delivery to make a positive difference to the lung health of the world.
Taiho Pharmaceutical Co., Ltd. (Tokyo, President: Masayuki Kobayashi) announced on March 24 that it has obtained approval in Japan from the Ministry of Health, Labour and Welfare to manufacture and market the oral combination anticancer drug "Lonsurf(R) combination tablet T15, T20" (nonproprietary names: trifluridine and tipiracil hydrochloride; development code: TAS-102), for the treatment of patients with unresectable advanced or recurrent colorectal cancer (only if refractory to standard therapies).
Air pollution has already been linked to a range of health problems. Now, a ground-breaking new study suggests pollution from traffic may put women at risk for another deadly disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alina Geller, DO 7650 Sw Beveland Rd, Ste 200, Portland, OR 97223-8692 Ph: (503) 601-3615 | Alina Geller, DO 1003 N Providence Dr Ste 340, Newberg, OR 97132-7521 Ph: (503) 538-2698 |
News Archive
AMRI today announced the acquisition of Hyaluron Inc., expanding AMRI's contract manufacturing capabilities to include cGMP manufacturing and sterile filling of parenteral drugs to the biopharmaceutical industry. AMRI has acquired all facilities and equipment as well as a highly trained and experienced staff of professionals with expertise in sterile GMP manufacturing. Purchase price, including debt, was approximately $27 million.
Endo Pharmaceuticals today issued a voluntary nationwide consumer level recall of Endocet (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg 100 count bottles, NDC 60951-712-70, Lot # 402415NV and #402426NV.
Experts from the world's leading lung organisations have come together for the first time to call for a worldwide effort to improve healthcare policies, systems and care delivery to make a positive difference to the lung health of the world.
Taiho Pharmaceutical Co., Ltd. (Tokyo, President: Masayuki Kobayashi) announced on March 24 that it has obtained approval in Japan from the Ministry of Health, Labour and Welfare to manufacture and market the oral combination anticancer drug "Lonsurf(R) combination tablet T15, T20" (nonproprietary names: trifluridine and tipiracil hydrochloride; development code: TAS-102), for the treatment of patients with unresectable advanced or recurrent colorectal cancer (only if refractory to standard therapies).
Air pollution has already been linked to a range of health problems. Now, a ground-breaking new study suggests pollution from traffic may put women at risk for another deadly disease.
› Verified 4 days ago
Jennifer E Lin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1003 Providence Dr, Suite 340, Newberg, OR 97132 Phone: 503-538-2698 Fax: 503-554-9328 | |
Carolyn Wood Siegele, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1003 Providence Dr Ste 340, Newberg, OR 97132 Phone: 503-538-2698 | |
Dr. Sylvana Elspeth Bennett, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1003 N Providence Dr Ste 340, Newberg, OR 97132 Phone: 503-538-2698 Fax: 503-554-9328 | |
Brandi Jean Spence, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1003 N Providence Dr Ste 340, Newberg, OR 97132 Phone: 503-538-2698 Fax: 503-554-9328 | |
Sandra Lee Emmons, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1003 Providence Dr, Ste 340, Newberg, OR 97132 Phone: 503-538-2698 Fax: 503-554-9328 | |
Dr. Margaret Elisa Barske, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1003 Providence Dr, Suite 340, Newberg, OR 97132 Phone: 503-538-2698 Fax: 503-554-9328 | |
Dr. Barbara Rajska, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1003 N Providence Dr Ste 340, Newberg, OR 97132 Phone: 503-538-2698 Fax: 503-554-9328 |